approval · primary record
CONCIZUMAB-MTCI
FDA · BLA · 2025-07-31
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-07-31 |
| Brand | ALHEMO |
| Sponsor | NOVO NORDISK INC |
| Route | Subcutaneous |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:49.442Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CONCIZUMAB-MTCI:2025-07-31
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.